Grace-Marie Turner testified on June 12 before the House Ways & Means Committee’s hearing on “Pathways to Universal Health Coverage.” She argued against dramatically expanding the role of government through Medicare for All or other new taxpayer-supported programs, such as Medicare Buy-In or a new “public option” insurer. She said we should instead target appropriate … [Read more...] about Grace-Marie Turner Testifies Before Congress About Universal Coverage
Grace-Marie Turner
HHS Marches Forward To Enhance Drug Price Transparency
Published on FORBES.com | HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to increase transparency and lower prescription drug prices since President Trump released his American Patients First blueprint in a Rose Garden ceremony a year ago. The blueprint offered nearly 30 policy recommendations to modernize … [Read more...] about HHS Marches Forward To Enhance Drug Price Transparency
The Left’s Utopian Health Care Promises
Published on FORBES.com | Democrats have been pulling levers for decades to exert greater and greater government control over our health sector. But the more government gets involved, the more dysfunctional the market becomes. The left now contends that the mess can only be solved with a complete government takeover. They believe their moment has come. Americans are … [Read more...] about The Left’s Utopian Health Care Promises
Grace-Marie Turner testifies on Medicare For All
A Tale of Two Big (Medicare) Mistakes
So here is a glimpse into one small part of the vast U.S. health care industry that shows the incredible difficulty government agencies have in setting accurate and fair payment rates for medical services, even when specifically directed by Congress to do so. It offers a cautionary tale for those who would put the entire health care system under government control. The players in … [Read more...] about A Tale of Two Big (Medicare) Mistakes
Americans are in no mood for another health care upheaval
Published in The Los Angeles Times | PAEONIAN SPRINGS, Va. Conservatives and progressives agree that everyone should be able to get health insurance and have access to quality health care. But the divide over how to accomplish that goal is wide and deep. Progressives believe the government should make decisions about allocation of the resources in our health sector while conservatives … [Read more...] about Americans are in no mood for another health care upheaval
A Closer Look At The Drug Rebate Proposal
Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal
Rebates And Drug Costs: What The New Proposal Would Mean
The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription drug prices—a topic that got serious attention before the Senate Finance Committee on Tuesday where top executives of seven major drug companies testified. The president announced his “American Patients First” agenda in May, offering nearly 30 policy recommendations to … [Read more...] about Rebates And Drug Costs: What The New Proposal Would Mean